<info type="ChemicalEntity">isoproterenol</info>-induced <info type="DiseaseOrPhenotypicFeature">cardiac hypertrophy</info> in <info type="OrganismTaxon">transgenic rats</info> with low <info type="GeneOrGeneProduct">brain angiotensinogen</info>.

We have previously shown that a permanent deficiency in the <info type="GeneOrGeneProduct">brain renin-angiotensin system (RAS)</info> may increase the sensitivity of the <info type="DiseaseOrPhenotypicFeature">baroreflex</info> control of <info type="DiseaseOrPhenotypicFeature">heart rate</info>. In this study we aimed at studying the involvement of the <info type="GeneOrGeneProduct">brain RAS</info> in the <info type="DiseaseOrPhenotypicFeature">cardiac reactivity</info> to the <info type="ChemicalEntity">beta-adrenoceptor (beta-AR)</info> agonist <info type="ChemicalEntity">isoproterenol (Iso)</info>. <info type="OrganismTaxon">Transgenic rats</info> with low <info type="GeneOrGeneProduct">brain angiotensinogen (TGR)</info> were used. In isolated hearts, <info type="ChemicalEntity">Iso</info> induced a significantly greater increase in <info type="DiseaseOrPhenotypicFeature">left ventricular (LV)</info> pressure and maximal contraction (<info type="GeneOrGeneProduct">+dP/dt(max)</info>) in the <info type="OrganismTaxon">TGR</info> than in the <info type="OrganismTaxon">Sprague-Dawley (SD)</info> rats. <info type="DiseaseOrPhenotypicFeature">LV hypertrophy</info> induced by <info type="ChemicalEntity">Iso treatment</info> was significantly higher in <info type="OrganismTaxon">TGR</info> than in <info type="OrganismTaxon">SD</info> rats (in g LV wt/100 g body wt, 0.28 +/- 0.004 vs. 0.24 +/- 0.004, respectively). The greater <info type="DiseaseOrPhenotypicFeature">LV hypertrophy</info> in <info type="OrganismTaxon">TGR rats</info> was associated with more pronounced downregulation of <info type="GeneOrGeneProduct">beta-AR</info> and upregulation of <info type="GeneOrGeneProduct">LV beta-AR kinase-1 mRNA</info> levels compared with those in <info type="OrganismTaxon">SD rats</info>. The decrease in the <info type="DiseaseOrPhenotypicFeature">heart rate (HR)</info> induced by the <info type="ChemicalEntity">beta-AR antagonist metoprolol</info> in conscious <info type="OrganismTaxon">rats</info> was significantly attenuated in <info type="OrganismTaxon">TGR</info> compared with <info type="OrganismTaxon">SD rats</info> (-9.9 +/- 1.7% vs. -18.1 +/- 1.5%), whereas the effect of parasympathetic blockade by <info type="ChemicalEntity">atropine</info> on <info type="DiseaseOrPhenotypicFeature">HR</info> was similar in both strains. These results indicate that <info type="OrganismTaxon">TGR</info> are more sensitive to <info type="ChemicalEntity">beta-AR agonist</info>-induced <info type="DiseaseOrPhenotypicFeature">cardiac inotropic response</info> and <info type="DiseaseOrPhenotypicFeature">hypertrophy</info>, possibly due to chronically low <info type="DiseaseOrPhenotypicFeature">sympathetic outflow</info> directed to the <info type="DiseaseOrPhenotypicFeature">heart</info>.